Eulon

Eulon (also known as Youlong Robot) develops intelligent rehabilitation exoskeleton systems for clinical gait training and home-based ankle rehabilitation. The company operates from Changsha, Hunan Province, with research collaboration through the Chinese Academy of Sciences Shenzhen Institutes of Advanced Technology (SIAT).

Company Overview

Founded around 2020, Eulon integrates independent R&D, manufacturing, and sales of exoskeleton robots. The company completed its first-generation exoskeleton prototype in 2020 and established a joint laboratory with SIAT in 2021. By 2022, Eulon had developed flexible exoskeleton technology enabling applications for hemiplegic patients.

In May 2025, the company secured a strategic investment of tens of millions of RMB from Lingxin Fund under Changsha City Development Group. This funding supports three strategic priorities: R&D advancement (including Hunan Province’s 2025 major research plan on human-machine integration exoskeleton technology), production capacity expansion to build China’s largest human-machine integration robot manufacturing base, and scenario development for outdoor hiking assistance applications.

Core Products

Tengyun Series Lower Limb Exoskeleton

A wearable robotic system designed for patients with lower limb motor impairments. The Tengyun series provides gait training and rehabilitation through powered assistance at hip and knee joints.

Ruyi Ankle Walking Assistance Training Device

An ankle-focused rehabilitation device that received NMPA Class II medical device registration in December 2024. Designed for ankle joint mobility training and walking pattern correction.

Panda Flexible Exoskeleton Robot

A soft exoskeleton system that assists hip joint movement, targeting elderly users and patients requiring hemiplegic gait correction. The flexible design offers improved comfort compared to rigid exoskeleton alternatives.

Yinghuo Flexible Exoskeleton

Another flexible exoskeleton product that obtained NMPA Class II registration in December 2024, expanding the company’s certified product portfolio.

Technology & Innovation

For hemiplegic gait correction and ankle rehabilitation, Eulon develops flexible exoskeleton systems combining bionic structural design with adaptive control algorithms backed by two NMPA Class II registrations.

Eulon’s exoskeleton technology centers on three core capabilities:

• Bionic Structural Design: Mechanical architecture that mirrors human joint biomechanics for natural movement patterns
• Hardware Control Technology: Proprietary actuator and sensor systems for responsive assistance
• Intelligent Software Technology: Adaptive control algorithms that learn user movement patterns

The company’s flexible exoskeleton technology earned recognition through multiple awards: 2023 Guangdong Province Science and Technology Award for Technological Invention (First Prize), 2023 Shenzhen Science and Technology Award for Technological Invention (First Prize nomination), and 2023 Chinese Association of Rehabilitation Medicine Science and Technology Award.

Market Presence

Eulon serves rehabilitation departments across hospitals in China, with products deployed in clinical settings for stroke recovery, spinal cord injury rehabilitation, and elderly mobility assistance. The Youlong outdoor product line has completed field testing at Yuelu Mountain and Hengshan Mountain for hiking assistance applications.

In September 2024, Eulon’s flexible exoskeleton robot was included in the Ministry of Industry and Information Technology’s “2024 Elderly Products Promotion Catalog,” indicating government endorsement for aging population applications.

Key Milestones

• 2020: Completed first-generation exoskeleton prototype
• 2021: Established joint laboratory with Chinese Academy of Sciences SIAT
• 2022: Achieved flexible exoskeleton technology for hemiplegic applications
• 2023: Received multiple provincial and national technology awards
• 2024 June: Launched “Jishan Youlong” public welfare project for mobility assistance
• 2024 September: Included in national elderly products promotion catalog
• 2024 December: Ruyi and Yinghuo products received NMPA Class II registration
• 2025 May: Completed strategic financing round from Changsha City Development Group

Frequently Asked Questions

What types of patients can benefit from Eulon exoskeletons?

Eulon exoskeletons primarily serve patients with lower limb motor impairments including stroke survivors, individuals with spinal cord injuries, and elderly patients requiring gait training. The flexible exoskeleton products also target hemiplegic patients needing walking pattern correction.

Does Eulon have regulatory approval for its products?

Yes, Eulon’s Ruyi ankle training device and Yinghuo flexible exoskeleton both received NMPA Class II medical device registration certificates in December 2024.

What is Eulon’s connection to the Chinese Academy of Sciences?

Eulon established a joint laboratory with the Shenzhen Institutes of Advanced Technology (SIAT) under the Chinese Academy of Sciences in 2021. This collaboration supports advanced research in human-machine integration and exoskeleton technology.